In vitro cytotoxicity activity of the methanol leaf extract of Picralima nitida on Human Colorectal Adenocarcinoma Cell lines (HT-29)

The anti-proliferative effect of the methanol leaf extract of Picralima nitida on Human Colorectal Adenocarcinoma Cell lines (HT-29) was investigated using the Cell Titer 96 MTT assay because Picralima nitida is a therapeutic herb used in ethnomedicine for the management of several disease conditions. Cells were cultured to confluence, trypsinized, and plated in 96-well plates for cell proliferation assay. Twenty four hours after plating, cells were treated with various concentrations (62.5, 125, 250 μm) of the extract along with the control in the presence or absence of Calphostin C (10 μm) or Tyrphostin (10 μm) and cultured for 24–72 h to determine effects of treatment on cell growth. MTT assay was performed at 24, 48 and 72. MTT assay was performed over 3 days. In vitro antiproliferative study showed that the extract at all concentrations caused cytotoxicity of the HT29 cells. The extract in the absence of the enzyme inhibitors caused a higher cell inhibition than in their presence with the 62.5 μm/ml causing a higher inhibitory effect on the cells. The ability of the methanol leaf extract of Picralima nitida with a higher antiproliferative property in the absence of the enzyme inhibitors is a pointer to its cytotoxic efficacy. It was thus concluded from this study that the plant extract from Picralima nitida has anti-proliferative/cytotoxic effect hence further evaluation on the constituents responsible for this effect

[1]  J. Kubásek,et al.  Test conditions can significantly affect the results of in vitro cytotoxicity testing of degradable metallic biomaterials , 2021, Scientific Reports.

[2]  M. Zarrati,et al.  The effect of ginger (Zingiber officinale) on chemotherapy‐induced nausea and vomiting in breast cancer patients: A systematic literature review of randomized controlled trials , 2019, Phytotherapy research : PTR.

[3]  E. Guerra,et al.  Effects of turmeric and curcumin on oral mucositis: A systematic review , 2019, Phytotherapy research : PTR.

[4]  A. Feyisayo,et al.  Assessment of antioxidant and antidiabetic properties of Picralima nitida seed extracts , 2019, Journal of Medicinal Plants Research.

[5]  Hao Chen,et al.  Acupuncture therapy for fibromyalgia: a systematic review and meta-analysis of randomized controlled trials , 2019, Journal of pain research.

[6]  L. Carlson,et al.  The Role of Hypnosis in Cancer Care , 2018, Current Oncology Reports.

[7]  X. Pei,et al.  Bloodletting puncture and cupping as an adjuvant therapy for breast cancer-related lymphedema in female adults: A non-randomized controlled pragmatic trial , 2018, Journal of Traditional Chinese Medical Sciences.

[8]  A. Camacho,et al.  Tyrphostin AG17 inhibits adipocyte differentiation in vivo and in vitro , 2018, Lipids in Health and Disease.

[9]  M. Kazanietz,et al.  Protein kinase C in cancer: The top five unanswered questions , 2017, Molecular carcinogenesis.

[10]  Imran Khan,et al.  MTT assay to evaluate the cytotoxic potential of a drug , 2017 .

[11]  M. Behzadifar,et al.  Effective Medicinal Plant in Cancer Treatment, Part 2: Review Study , 2017, Journal of evidence-based complementary & alternative medicine.

[12]  Beom-Tae Kim,et al.  Total Synthesis of Amino‐Functionalized Calphostin Analogs as Potent and Selective Inhibitors of Protein Kinase C (PKC) , 2016 .

[13]  J. Syssa-Magalé,et al.  Phytochemical screening and evaluation of the antioxidant activity of the polar extracts Picralima nitida Stapf. (Apocynaceae) family , 2016 .

[14]  G. Koffuor,et al.  Antitussive, expectorant and analgesic effects of the ethanol seed extract of Picralima nitida (Stapf) Th. & H. Durand , 2016, Research in pharmaceutical sciences.

[15]  O. Aina,et al.  In vivo anti-plasmodial activities and toxic impacts of lime extract of a combination of Picralima nitida, Alstonia boonei and Gongronema latifolium in mice infected with Chloroquine-sensitive Plasmodium berghei. , 2016, African health sciences.

[16]  Yuyin Xu,et al.  Study of the in vitro cytotoxicity testing of medical devices. , 2015, Biomedical Reports.

[17]  B. Jang,et al.  Identification of KMU-3, a Novel Derivative of Gallic Acid, as an Inhibitor of Adipogenesis , 2014, PloS one.

[18]  Jeong-Hun Kang Protein Kinase C (PKC) Isozymes and Cancer , 2014 .

[19]  F. Boyom,et al.  Antioxidant and antidiabetic profiles of two African medicinal plants: Picralima nitida (Apocynaceae) and Sonchus oleraceus (Asteraceae) , 2013, BMC Complementary and Alternative Medicine.

[20]  A. Newton,et al.  Protein kinase C pharmacology: refining the toolbox. , 2013, The Biochemical journal.

[21]  N. Obasi,et al.  Nutritional Evaluation, Phytochemical Screening and Antimicrobial Effects of Aqueous Extract of Picralima nitida Peel , 2012 .

[22]  P. Ubulom,et al.  Larvicidal and Antifungal Properties of Picralima nitida (Apocynaceae) Leaf Extracts , 2012 .

[23]  K. Turpaev,et al.  Benzylidenemalononitrile compounds as activators of cell resistance to oxidative stress and modulators of multiple signaling pathways. A structure-activity relationship study. , 2011, Biochemical pharmacology.

[24]  A. Gray,et al.  Glucose uptake stimulatory effect of akuammicine from picralima nitida (Apocynaceae) , 2010 .

[25]  P. Maher,et al.  Tyrphostins Protect Neuronal Cells from Oxidative Stress* , 2002, The Journal of Biological Chemistry.

[26]  R. Bhatia,et al.  Tyrphostin AG957, a tyrosine kinase inhibitor with anti-BCR/ABL tyrosine kinase activity restores β1 integrin-mediated adhesion and inhibitory signaling in chronic myelogenous leukemia hematopoietic progenitors , 1998, Leukemia.

[27]  N. Zengi̇n,et al.  Acupuncture as a complementary treatment for cancer patients receiving chemotherapy. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[28]  P. Langer,et al.  Medicinal uses, phytochemistry and pharmacology of Picralima nitida (Apocynaceae) in tropical diseases: a review. , 2014, Asian Pacific journal of tropical medicine.

[29]  Michael F. Wolf,et al.  Chapter II.3.3 – In Vitro Assessment of Cell and Tissue Compatibility , 2013 .